3 employees
Calyxha is developing novel therapies targeting tissue degeneration that is the fundamental underlying cause of major human diseases.
2019
$1.1M
from 1 investors over 1 rounds
Calyxha Biotechnologies GmbH raised $1.1M on February 28, 2020
Investors: Kinled Holding Ltd